Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse model

NMR in Biomedicine

Volumn 24, Issue 2, 2011, Pages 163-169

  Kim, Joong Hee ^a   Wu, Tzy Haw ^b   Budde, Matthew D ^c   Lee, Jin Moo ^d   Song, Sheng Kwei ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Axial and radial diffusivity; Cervical spinal cord; Diffusion anisotropy; Diffusion tensor imaging; G93A SOD1; Mice

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CERVICAL SPINAL CORD; DIFFUSION ANISOTROPY; DIFFUSION TENSOR IMAGING; G93A-SOD1; MICE; RADIAL DIFFUSIVITY;

ANIMALS; ANISOTROPY; BRAIN; DOSIMETRY; MAGNETIC RESONANCE IMAGING; NEURONS; RADIOLOGY; SURFACE DIFFUSION;

TENSORS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BRAIN STEM; CERVICAL SPINAL CORD; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; HISTOLOGY; LUMBAR SPINAL CORD; MOTONEURON; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SPINAL CORD ATROPHY; TRANSGENIC MOUSE; WHITE MATTER;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; BRAIN STEM; DIFFUSION TENSOR IMAGING; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; SPINAL CORD; SUPEROXIDE DISMUTASE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79951839343     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1567     Document Type: Article

References (46)

1. Weydt P, Hong SY, Kliot M, Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport, 2003; 14: 1051-1054.
2. Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. 2008; 115: 97-114.
3. Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve, 2006; 33: 598-608.
4. Przedborski S. Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance. Neurologist, 2004; 10: 1-7.
5. Malaspina A, de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain. Res. Brain. Res. Rev. 2004; 45: 213-229.
6. Tsuchiya K, Ikeda K, Haga C, Kobayashi T, Morimatsu Y, Nakano I, Matsushita M. Atypical amyotrophic lateral sclerosis with dementia mimicking frontal Pick's disease: a report of an autopsy case with a clinical course of 15 years. Acta Neuropathol. 2001; 101: 625-630.
7. Martin LJ, Price AC, Kaiser A, Shaikh AY, Liu Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review). Int. J. Mol. Med. 2000; 5: 3-13.
8. Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann. NY Acad. Sci. 2005; 1064: 61-77.
9. Pioro EP. Proton magnetic resonance spectroscopy (1H-MRS) in ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000; 1 (Suppl 2): S7-16.
10. Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology, 1999; 53: 1051-1058.
11. Brooks BR, Bushara K, Khan A, Hershberger J, Wheat JO, Belden D, Henningsen H. Functional magnetic resonance imaging (fMRI) clinical studies in ALS - paradigms, problems and promises. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000; 1 (Suppl 2): S23-32.
12. Pagani E, Horsfield MA, Rocca MA, Filippi M. Assessing atrophy of the major white matter fiber bundles of the brain from diffusion tensor MRI data. Magn. Reson. Med. 2007; 58: 527-534.
13. Dengler R, von Neuhoff N, Bufler J, Krampfl K, Peschel T, Grosskreutz J. Amyotrophic lateral sclerosis: new developments in diagnostic markers. Neurodegener. Dis. 2005; 2: 177-184.
14. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009; 8: 94-109.
15. Angenstein F, Niessen HG, Goldschmidt J, Vielhaber S, Ludolph AC, Scheich H. Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport, 2004; 15: 2271-2274.
16. Niessen HG, Angenstein F, Sander K, Kunz WS, Teuchert M, Ludolph AC, Heinze HJ, Scheich H, Vielhaber S. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp. Neurol. 2006; 201: 293-300.
17. Wilson JM, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA. Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy. Neuroimage, 2004; 23: 336-343.
18. Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2007; 25: 1669-1677.
19. Bilgen M. Magnetic resonance microscopy of spinal cord injury in mouse using a miniaturized implantable RF coil. J. Neurosci. Methods, 2007; 159: 93-97.
20. Callot V, Duhamel G, Cozzone PJ, Kober F. Short-scan-time multi-slice diffusion MRI of the mouse cervical spinal cord using echo planar imaging. NMR Biomed. 2008; 21: 868-877.
21. Kim JH, Haldar J, Liang ZP, Song SK. Diffusion tensor imaging of mouse brain stem and cervical spinal cord. J. Neurosci. Methods, 2009; 176: 186-191.
22. Hassen WB, Begou M, Traore A, Moussa AB, Boehm N, Ghandour MS, Renou JP, Boespflug-Tanguy O, Bonny JM. Characterisation of spinal cord in a mouse model of spastic paraplegia related to abnormal axono-myelin interactions by in vivo quantitative MRI. Neuroimage, 2009; 46: 1-9.
23. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998; 338: 278-285.
24. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol. Dis. 2006; 21: 626-632.
25. Stejskal ET. Spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965; 42(1): 288-292.
26. Koay CG, Chang LC, Carew JD, Pierpaoli C, Basser PJ. A unifying theoretical and algorithmic framework for least squares methods of estimation in diffusion tensor imaging. J. Magn. Reson. 2006; 182: 115-125.
27. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 2005; 233: 183-198.
28. Bain AC, Raghupathi R, Meaney DF. Dynamic stretch correlates to both morphological abnormalities and electrophysiological impairment in a model of traumatic axonal injury. J. Neurotrauma, 2001; 18: 499-511.
29. Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, Song SK. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed. 2008; 21: 589-597.
30. Rasband WS. ImageJ. US National Institutes of Health: Bethesda, MD, 1997-2005.
31. Gurney ME. What transgenic mice tell us about neurodegenerative disease. Bioessays, 2000; 22: 297-304.
32. Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, Wong LF, Bilsland LG, Greensmith L, Kingsman SM, Mitrophanous KA, Mazarakis ND, Azzouz M. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 2005; 11: 429-433.
33. Zang DW, Yang Q, Wang HX, Egan G, Lopes EC, Cheema SS. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2004; 20: 1745-1751.
34. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 1994; 264: 1772-1775 .
35. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 1995; 14: 1105-1116.
36. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage, 2003; 20: 1714-1722.
37. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage, 2002; 17: 1429-1436.
38. Kim JH, Loy DN, Liang HF, Trinkaus K, Schmidt RE, Song SK. Noninvasive diffusion tensor imaging of evolving white matter pathology in a mouse model of acute spinal cord injury. Magn. Reson. Med. 2007; 58: 253-260.
39. Loy DN, Kim JH, Xie M, Schmidt RE, Trinkaus K, Song SK. Diffusion tensor imaging predicts hyperacute spinal cord injury severity. J. Neurotrauma, 2007; 24: 979-990.
40. Schwartz ED, Cooper ET, Chin CL, Wehrli S, Tessler A, Hackney DB. Ex vivo evaluation of ADC values within spinal cord white matter tracts. Am. J. Neuroradiol. 2005; 26: 390-397.
41. Schwartz ED, Hackney DB. Diffusion-weighted MRI and the evaluation of spinal cord axonal integrity following injury and treatment. Exp. Neurol. 2003; 184: 570-589.
42. Gribkoff VK, Bozik ME. KNS-760704 [(6R)-4, 5, 6, 7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis. CNS Neurosci. Ther. 2008; 14: 215-226.
43. Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M, Williamson KS. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal, 2006; 8: 2075-2087.
44. Sathasivam S, Ince PG, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol. Appl. Neurobiol. 2001; 27: 257-274.
45. Poon HF, Hensley K, Thongboonkerd V, Merchant ML, Lynn BC, Pierce WM, Klein JB, Calabrese V, Butterfield DA. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice - a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005; 39: 453-462.
46. Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology, 2007; 68: 1576-1582.